Smilen Pharmaceuticals Private Limited
About Smilen Pharmaceuticals Private Limited
Data last updated:
Smilen Pharmaceuticals Private Limited is a private limited company based in Dombivli, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 May 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2022PTC381925.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priya Radheshyam Vishwakarma and Madhavi Subhash Pawar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No – 25 Vjj Prabha Complex Patkar Road Dombivli, Maharashtra, India – 421201.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.24 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19,292 (net margin 0.7%) and EBITDA of ₹44,548 (EBITDA margin 1.7%).
Company details
Contact details
Smilen Pharmaceuticals Private Limited's registered office is in Dombivli, Maharashtra.
- Registered AddressOffice No – 25 Vjj Prabha Complex Patkar Road Dombivli, Maharashtra, India – 421201
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Smilen Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Smilen Pharmaceuticals Private Limited, buy the company report.
Financials of Smilen Pharmaceuticals Private Limited
FY 2025 filings availableSmilen Pharmaceuticals Private Limited reported revenue of ₹26.24 Lakh (up 164% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 164% in the latest year. EBITDA rose 158% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹44,548 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹19,292 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.7% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Smilen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Smilen Pharmaceuticals Private Limited
Smilen Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priya Radheshyam Vishwakarma | Director | 04 May 2022 | 4 Years 5 Months | Current |
| Madhavi Subhash Pawar | Additional Director | 17 Sep 2024 | 2 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Smilen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smilen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Smilen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Smilen Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Madhavi Subhash Pawar was appointed as Additional Director on 17 Sep 2024.
Frequently asked questions
Smilen Pharmaceuticals is an active private limited company based in Dombivli, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 May 2022 (4+ years old) and is registered under CIN U24100MH2022PTC381925.
Smilen Pharmaceuticals has 2 current directors:
- Priya Radheshyam Vishwakarma - Director
- Madhavi Subhash Pawar - Additional Director
The latest financial statements of Smilen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Smilen Pharmaceuticals is U24100MH2022PTC381925. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smilen Pharmaceuticals was incorporated on 04 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Madhavi Subhash Pawar was appointed as Additional Director on 17 Sep 2024. Sudhir Pratap Yadav ceased to be Director on 17 Sep 2024. Priya Radheshyam Vishwakarma was appointed as Director on 04 May 2022.
The registered office of Smilen Pharmaceuticals is at Office No – 25 Vjj Prabha Complex Patkar Road Dombivli, Maharashtra, India – 421201.
Smilen Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Smilen Pharmaceuticals can be reached at its registered office: Office No – 25 Vjj Prabha Complex Patkar Road Dombivli, Maharashtra, India – 421201.
Smilen Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.